Scientists have created the first map of protein changes in Alzheimer's disease
Alzheimer's disease affects almost the entire brain, but different types of cells can react differently to the development of the disease. To study these processes in more detail, the researchers created the first cell-by-cell map of protein changes. It allowed us to detect thousands of changes that remained unnoticeable when analyzing the entire brain tissue, and to identify possible mechanisms of interaction between cells. The new features of the disease have been discovered in the Izvestia article.
The first protein map in Alzheimer's disease
The study is published in the journal Neuron. Specialists at St. Jude Children's Research Hospital have developed an atlas of protein changes in Alzheimer's disease, taking into account specific types of brain cells. To do this, they used two mouse models of the disease and studied more than 13,000 proteins at different stages of the disease.
As a result, the researchers found more than 3,000 proteins, the level of which varied in individual cell types. About 78% of these changes had previously failed to be detected by analyzing mixed brain tissue samples. The scientists obtained particularly noticeable results when studying microglia, immune cells of the central nervous system. Almost all of the protein changes found in this cell population had previously gone unnoticed.
Junmin Peng, computational biology specialist and author of the study
This is the first known proteomic analysis of Alzheimer's disease with cell type resolution. When we compared our data with the results of whole tissue studies, it turned out that a significant part of the detected changes in protein levels are new.
The analysis of individual cells helped to detect hidden changes
Previously, researchers often used RNA sequencing of individual cells to determine which genes are active in different parts of the brain. However, this method shows the activity of genes, rather than the direct amount of proteins produced. Proteomic analysis, on the contrary, allows us to study the proteins themselves, but it was mainly performed on samples containing many different types of cells. With this approach, the results are combined, and changes characteristic of individual cell populations can be lost against the general background.
To get a more detailed picture, the team combined several methods: next-generation mass spectrometry, single-cell RNA sequencing, and spatial omix technologies. This made it possible to compare the genetic activity with the level of proteins and determine which cells are undergoing changes.
Jiyang Yu, computational biology specialist and co-author of the study
Thanks to the high resolution of the proteomic analysis of individual cell types, we have gained an additional level of information. It turned out to be especially important to compare samples examined by different methods and at different levels of detail.
According to the scientist, this approach helps to study the mechanisms of the disease more deeply and to identify interactions between different brain cells, in particular between microglia and astrocytes.
Microglia have proven to be an important source of previously unnoticed changes.
The researchers paid special attention to microglia. These cells belong to the immune system of the central nervous system and are involved in maintaining its normal functioning. In Alzheimer's disease, they are of particular interest because they contain many genes associated with the risk of developing the disease.
The analysis showed that almost all of the detected protein changes in microglia had not previously been recorded in the study of whole brain tissue. This indicates that standard methods of analysis could conceal a significant part of the processes occurring in these cells.
The authors believe that the data obtained will help to determine more precisely which proteins and cellular mechanisms may be involved in the development of the disease. In particular, the study revealed potential factors that can be further studied as possible participants in pathological processes. However, the changes found by themselves do not yet prove that specific proteins cause the disease or directly determine the rate of its development. Additional experiments are needed to establish their role.
Proteins can transmit signals between different brain cells
A comparison of data on gene activity and protein levels revealed another feature: a protein can be found in one cell, although it is formed in another. This indicates a possible intercellular communication system in which some cells secrete proteins, while others use them to transmit signals.
One example is pleiotrophin. The researchers found a high level of RNA responsible for its production in astrocytes, while the protein itself was present in large quantities in microglia. Scientists have suggested that astrocytes can produce pleiotrophin and release it into the external environment, after which the protein acts on microglia. Thus, changes in one cell population can potentially affect the work of another.
Junmin Peng
Since these proteins are secreted, this indicates an interesting form of intercellular communication. Gene regulation can occur in astrocytes, but after formation and isolation, proteins perform their functions already in microglia.
The authors believe that such interactions can help to better understand the complex processes occurring in the brain in Alzheimer's disease. However, the role of the identified protein signals in the development of the disease has yet to be verified.
Atlas will help to study the mechanisms of Alzheimer's disease
The created map and its accompanying datasets are publicly available. The researchers hope that other scientific groups will be able to use them to study changes in specific brain cells, compare protein and genetic data, and search for new disease mechanisms.
According to the authors, this approach can become the basis for further studies of interactions between microglia, astrocytes and other cells of the nervous system. It will also make it possible to more accurately determine which changes are associated with specific cell populations, and which reflect general processes in the brain.
Juan Yang, co-author of the study
We hope that our research will become a useful example for future multi-domain work.
At the same time, the scientists emphasize that the results have so far been obtained in two mouse models of Alzheimer's disease. Therefore, the detected changes cannot be automatically transferred to humans. The next stage of the research is to verify the identified proteins and suspected intercellular interactions on human material.
Переведено сервисом «Яндекс Переводчик»